Skip to main content
Year archive

SK Bioscience Co.,Ltd — 2023 filings

All 58 regulatory filings released by SK Bioscience Co.,Ltd (302440) in 2023, sourced directly from the official regulator.

58 Filings
2023 Period
2023 filings (58)
Filing Released Lang
주식등의대량보유상황보고서(일반)
Major Shareholding Notification
2023-12-19 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-12-19 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-12-19 Korean
최대주주등소유주식변동신고서
Major Shareholding Notification
2023-12-19 Korean
투자판단관련주요경영사항(21가 폐렴구균백신(GBP410)의 미국 제3상 임상시험계획 (IND) 신청)
Regulatory Filings
2023-12-11 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2023-12-06 Korean
대규모기업집단현황공시[분기별공시(개별회사용)]
Regulatory Filings
2023-11-30 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings
2023-11-29 Korean
유형자산취득결정
Regulatory Filings
2023-11-28 Korean
분기보고서 (2023.09)
Interim / Quarterly Report 9M 2023
2023-11-14 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Q3 2023
2023-10-26 Korean
기업설명회(IR)개최(안내공시)
Report Publication Announcement
2023-10-26 Korean
기업설명회(IR)개최(안내공시)
Report Publication Announcement
2023-10-23 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-09-12 Korean
투자판단관련주요경영사항(COVID-19 백신 스카이코비온(GBP510)의 유럽의약품청(EMA) 조건부허가(CMA) 신청 철회 결정)
Regulatory Filings
2023-09-01 Korean
대규모기업집단현황공시[분기별공시(개별회사용)]
Regulatory Filings
2023-08-31 Korean
단일판매ㆍ공급계약체결
Regulatory Filings
2023-08-21 Korean
반기보고서 (2023.06)
Interim / Quarterly Report H1 2023
2023-08-11 Korean
지급수단별ㆍ지급기간별지급금액및분쟁조정기구에관한사항
Regulatory Filings
2023-08-11 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings
2023-08-09 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings
2023-08-09 Korean
타법인주식및출자증권취득결정
M&A Activity
2023-08-09 Korean
[기재정정]투자판단관련주요경영사항
Regulatory Filings
2023-08-09 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings
2023-07-31 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Q2 2023
2023-07-28 Korean
기업설명회(IR)개최(안내공시)
Report Publication Announcement
2023-07-28 Korean
기업설명회(IR)개최(안내공시)
Report Publication Announcement
2023-07-19 Korean
불성실공시법인지정
Regulatory Filings
2023-07-10 Korean
투자판단관련주요경영사항(COVID-19 백신 스카이코비원 세계보건기구(WHO) 긴급사용목록(Emergency Use Listing) 등재)
Regulatory Filings
2023-06-19 Korean
불성실공시법인지정예고
Regulatory Filings
2023-06-15 Korean
단일판매ㆍ공급계약체결
Regulatory Filings
2023-06-14 Korean
기업지배구조보고서공시
Governance Information
2023-05-31 Korean
대규모기업집단현황공시[연1회공시및1/4분기용(개별회사)]
Major Shareholding Notification
2023-05-31 Korean
투자판단관련주요경영사항
Regulatory Filings
2023-05-30 Korean
분기보고서 (2023.03)
Interim / Quarterly Report Q1 2023
2023-05-12 Korean
[기재정정]단일판매ㆍ공급계약체결
Regulatory Filings
2023-04-28 Korean
장래사업ㆍ경영계획(공정공시)
Management Reports
2023-04-27 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Q1 2023
2023-04-27 Korean
기업설명회(IR)개최(안내공시)
Report Publication Announcement
2023-04-21 Korean
기업설명회(IR)개최(안내공시)
Report Publication Announcement
2023-04-21 Korean
투자판단관련주요경영사항(COVID-19 백신 GBP510의 부스터샷 제 3상 임상시험 Top-line 결과 발표)
Regulatory Filings
2023-04-12 Korean
정기주주총회결과
Declaration of Voting Results & Voting Rights Announcements
2023-03-27 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information
2023-03-27 Korean
사업보고서 (2022.12)
Annual Report FY 2022
2023-03-17 Korean
감사보고서제출
Audit Report / Information FY 2022
2023-03-15 Korean
투자판단관련주요경영사항
Regulatory Filings
2023-03-06 Korean
주주총회소집공고
Proxy Solicitation & Information Statement
2023-03-03 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement
2023-03-03 Korean
주주총회소집결의
AGM Information
2023-03-03 Korean
대규모기업집단현황공시[분기별공시(개별회사용)]
Audit Report / Information Q2 2024
2023-02-28 Korean
기업설명회(IR)개최(안내공시)
Report Publication Announcement
2023-02-08 Korean
매출액또는손익구조30%(대규모법인은15%)이상변경
Earnings Release FY 2022
2023-02-08 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Q4 2022
2023-02-08 Korean
신규시설투자등
Regulatory Filings
2023-02-08 Korean
결산실적공시예고(안내공시)
Report Publication Announcement
2023-01-19 Korean
기업설명회(IR)개최(안내공시)
Report Publication Announcement
2023-01-19 Korean
투자판단관련주요경영사항(노바백스 코로나19 백신 국내 품목허가 변경 승인(부스터샷 적응증 추가))
Regulatory Filings
2023-01-16 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing
2023-01-05 Korean